Inhibition of Leukocyte Chemotaxis by Factor in Alloxan-Induced Diabetic Rat Plasma

Author:

Pereira Maria Adelaide A1,Sannomiya Paulina1,Leme João Garcia1

Affiliation:

1. Department of Pharmacology, Institute of Biomedical Sciences, University of Sāo Paulo Sāo Paulo, Brazil

Abstract

The early local exudative cellular reaction in an inflammatory lesion was impaired in alloxan-induced diabetic rats due to reduced migration of neutrophils to the inflamed area. Neutrophils, however, were capable of moving from reserve compartments into blood in these animals. Furthermore, the functional integrity of their surface membranes, assessed by the capacity of the cells to adhere to nylon fiber, was not altered by alloxan diabetes. An intrinsic cellular defect also did not occur, because the cells were capable of responding to chemotactic stimuli in the Boyden chamber system, provided they were suspended in Eagle's medium or normal serum. Suspended in the corresponding diabetic serum, a blockade of the chemotactic response was observed. Increasing concentrations of diabetic serum, added to a suspension containing neutrophils collected from normal donors, progressively inhibited the response of the cells to a chemotactic stimulus. Hyperglycemia alone or hyperosmolality secondary to hyperglycemia, the presence of ketone bodies, or a direct effect of alloxan did not explain the results. In addition, the capacity to generate chemotactic factors remained intact in diabetic serum. Pretreatment of the diabetic animals with insulin resulted in a gradual recovery of the chemotactic response in vivo and in vitro. We conclude that alloxan-induced diabetic rat serum contains a substance that inhibits neutrophil chemotaxis and that insulin administration is essential for the clearance of this substance from plasma.

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3